title: Treatment of intracerebral hemorrhage: what should we do now?
abstract: Intracerebral hemorrhage (ICH) is the most lethal type of stroke. Level I, class A evidence of effective treatment is lacking. Many issues surrounding the optimal management of ICH, such as blood pressure control, prevention of hematoma growth, containing brain edema, and preserving cerebral perfusion, need more rigorous clinical research. However, when selected appropriately, the mortality of certain patients with ICH may improve when treated early with minimally invasive neurosurgery or perhaps intravenous hemostatics. In addition, patients with ICHs may have better outcome when medical care is optimized according to the published ICH treatment guidelines. Stem cell therapy has shown promise for better functional recovery.
authors.affiliation: University of Illinois College of Medicine at Peoria, 530 Northeast Glen Oak, Peoria, IL 61637, USA.
authors.forename: David Z
authors.initials: DZ
authors.lastname: Wang
authors.forename: Arun V
authors.initials: AV
authors.lastname: Talkad
mesh_terms: D001794:Blood Pressure; D002543:Cerebral Hemorrhage / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D002560:Cerebrovascular Circulation / Q000502:physiology; D006406:Hematoma / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000150:complications; D008279:Magnetic Resonance Imaging; D018696:Neuroprotective Agents / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D018696:Neuroprotective Agents